SCHEMBL20176688

SCHEMBL20176688

Brc1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.43
ENPP3 O14638 1/20 0.43
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
CA12 O43570 4/20 0.39
CA9 Q16790 4/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
TNF P01375 1/20 0.39
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
PRKCZ Q05513 1/20 0.35
PPARG P37231 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29776150 1.00 ENPP1 (0.43) ENPP1ENPP3HDAC8HDAC6MEN1
SCHEMBL15158541 0.88 MEN1 (0.44) ENPP1ENPP3MEN1KMT2ALMNA
SCHEMBL28491556 0.85 HDAC8 (0.50) ENPP1ENPP3HDAC8HDAC6CA12
SCHEMBL1534980 0.83 CYP11B2 (0.48) MEN1KMT2ALMNAMAPTCYP11B1
SCHEMBL29776157 0.82 NPC1 (0.47) MAPTCA2MCL1
SCHEMBL20176784 0.82 NPC1 (0.47) MAPTCA2MCL1
SCHEMBL20176544 0.81 MAPK1 (0.43) MEN1KMT2ALMNAMAPTCYP11B1
SCHEMBL29776268 0.81 MAPK1 (0.43) MEN1KMT2ALMNAMAPTCYP11B1
SCHEMBL20909418 0.81 ENPP1 (0.43) ENPP1ENPP3HDAC8HDAC6CA12
SCHEMBL20176684 0.81 HDAC8 (0.44) ENPP1ENPP3HDAC8HDAC6CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
CN-110023305-B Organic light-emitting compound and organic electroluminescent element using same 索路思高新材料有限公司 2022-08-09 CN disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 ENPP1 824/4885ENPP3 1028/4885HDAC8 4586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.